JB Chemicals & Pharmaceuticals Q3 Results
- BSE: 506943
- NSE: JBCHEPHARM
- ISIN: INE572A01036
- Sector: Biotechnology & Drugs
BSE
1,764.7
4.25 (0.24%)
4.25 (0.24%)Volume1.01 K
Updated: Wed 15 Jan, 2025 | 15:20:42
NSE
1,765.054.10 (0.23%)
4.10 (0.23%)Volume23.19 K
Updated: Wed 15 Jan, 2025 | 15:06:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - JB Chemicals & Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 844.51 | 881.74 | -4.22% | 792.71 | 6.53% |
| Selling/ General/ Admin Expenses Total | 151.68 | 148.28 | 2.29% | 138.33 | 9.65% |
| Depreciation/ Amortization | 34.03 | 32.17 | 5.78% | 28.40 | 19.82% |
| Other Operating Expenses Total | 196.08 | 191.75 | 2.26% | 180.60 | 8.57% |
| Total Operating Expense | 655.42 | 670.37 | -2.23% | 646.34 | 1.40% |
| Operating Income | 189.09 | 211.37 | -10.54% | 146.37 | 29.19% |
| Net Income Before Taxes | 183.95 | 208.66 | -11.84% | 141.20 | 30.28% |
| Net Income | 133.57 | 150.59 | -11.30% | 106.10 | 25.89% |
| Diluted Normalized EPS | 8.46 | 9.54 | -11.32% | 6.79 | 24.69% |